Medical

Explore the macro trends reshaping oncology, from the pace of FDA approvals and liquid biopsy to AI, and what each means for pharma brand teams.

Women face diagnostic delays and worsened outcomes due to gender bias. Discover the key conditions driving this gap and how brands can help close it.

Why do some effective therapies struggle with adherence? Discover how closing the “felt benefit gap” can improve patient initiation, trust, and persistence.

Rare disease innovation is accelerating, but education is lagging. Learn why rare disease education must evolve to build HCP confidence and translate science into action.

Investing in women’s health benefits everyone. Learn how healthcare brands are equalizing health and what they can do to keep growing their impact.

Read how ASH 2025 highlighted AI moving from promise to practice in hem-onc and what it means for shaping the future of care.

See what the FDA’s September enforcement letters, released from September 25th to 30th, reveal about HCP promotion.

See what 89 new FDA CRLs reveal about current review trends and how early insight can help teams mitigate risk and strengthen submissions.

The FDA is prioritizing comprehension. Learn how to align promotional content with evolving expectations around clarity, risk balance, and consumer understanding.

Reimagine peer-to-peer learning with “Designed to Engage.” Download the cheatsheet to create flexible, personalized, and interactive HCP education experiences.

Discover HCP AI FocusGroup™, an AI-powered tool for precise, predictive, and actionable HCP insights. Download the intake form to customize your virtual focus group.

Lifestyle psychiatry is complementing pharmacotherapy in mental health care, creating opportunities for brands in the space.

Explore how the FDA’s release of 200+ CRLs reveals patterns in regulatory submission failures, helping teams anticipate risks, refine strategy, and accelerate approval.

Traditional pharma speaker programs are outdated. Learn how HCP education must evolve into personalized, interactive, omnichannel experiences.

In this interview, Klick Health’s Jasmine Singh sits down with Dr. Rahul Banerjee from Fred Hutchinson Cancer Institute to discuss the concept of “Time Toxicity” in cancer care. Th...

Read how ASCO 2025 spotlighted breakthrough innovations and their impact on the cancer care community—and what it means for teams shaping the future of oncology.

Understand how life sciences leaders can ease the cognitive and emotional load oncologists face amid data overload, burnout, and nonstop decision-making.

It’s time to consider how the hidden burden of time toxicity shapes cancer care. Explore why addressing it can unlock better outcomes, equity, and a positive brand experience.

Oncology engagement is evolving. Learn how AI, real-world data, and digital behaviors are reshaping how we connect with time-pressed HCPs in a fast-moving field.

See how AI, telemedicine, and digital screening are transforming cancer care—and why true equity demands broadband access, trust, and systemic investment.

AI and automation are transforming MLR review by improving efficiency, reducing rework, and enabling compliant content reuse. Discover how to unlock speed without sacrificing accur...

Focus groups can’t keep pace with the urgency of oncology. AI-driven simulations are changing the game—delivering insights on how oncologists respond to efficacy, safety, and compe...

Pharma is evolving. Explore key shifts from Pharma USA 2025, from operationalizing precision to building trust, access, and human-centric engagement.

Jasmine Singh, EVP Medical Strategy, Klick Health, sits down with Dr. Scott Kopetz from MD Anderson to talk about minimal residual disease and why cancer that doesn’t show up on a ...

Klick’s 5P framework empowers medical affairs teams to enhance DOL engagement using strategic profiling, planning, partnering, and social media to drive lasting medical impact.